Vivos Therapeutics Inc. (NASDAQ: VVOS)
$2.80
-0.0150 ( -0.53% ) 68.0K
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Market Data
Open
$2.80
Previous close
$2.81
Volume
68.0K
Market cap
$9.38M
Day range
$2.67 - $2.94
52 week range
$1.91 - $48.79
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | May 17, 2024 |
8-k | 8K-related | 14 | May 15, 2024 |
10-q | Quarterly Reports | 79 | May 14, 2024 |
8-k | 8K-related | 14 | May 06, 2024 |
8-k | 8K-related | 14 | Mar 29, 2024 |
10-k | Annual reports | 92 | Mar 28, 2024 |
8-k | 8K-related | 19 | Feb 15, 2024 |
8-k | 8K-related | 12 | Nov 30, 2023 |
10-q | Quarterly Reports | 83 | Nov 14, 2023 |
8-k | 8K-related | 19 | Nov 02, 2023 |